Chromatography
Analytical solution for the characterisation
Mar 23 2010
Waters UPLC® analytical solution for the characterisation of 2-AB labelled glycans from glycoproteins combines Waters ACQUITY® UPLC BEH Glycan Columns with the ACQUITY UPLC System equipped with fluorescence detection. With this product, scientists can meet US FDA requirements for accurately characterising glycans attached to therapeutic proteins to ensure biopharmaceutical product efficacy and safety.
This UPLC solution has been shown to be up to three times faster than traditional HPLC for the analysis of 2-aminobenzamide (2AB)-labelled glycans from human IgG. All ACQUITY UPLC BEH Glycan columns are
quality-control tested with relevant labeled glycan standards for consistent batch-to-batch column performance and to meet expectations for their long-term use in validated methods.
Waters ACQUITY UPLC BEH Glycan columns provide superior resolution for a wide range of glycans and are produced with the Waters Designed for Six Sigma (DFSS) Phase II ACQUITY UPLC column manufacturing process. This process produces superior long term performance by maximising efficiency while minimising column-to-column variability.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark
Aug 28 2024 Phnom Penh, Cambodia